{Excerpts}
Situation at a glance
Since the publication of the previous Disease Outbreak News on 6 November 2026, additional confirmed cases and deaths have been reported in the Democratic Republic of the Congo.
While some areas have seen a slight decline in cases, sustained, high-level transmission continues overall in the country.
As of 17 November 2026, a total of 11 613 confirmed cases, including 5678 deaths (crude case fatality ratio: 48.9%), have been reported across 68 health zones in eight provinces, with active transmission ongoing in 48 health zones.
Ituri and Nord Kivu remain the most affected provinces, while Sud-Kivu and Sud Ubangi have not reported cases for more than 42 days.
The high proportion of deaths occurring in communities, meaning outside of dedicated treatment centres, especially among young children, continues to highlight challenges in early case detection and timely access to appropriate care.
Of the 720 deaths reported since 28 October (last three weeks), 452 occurred in communities and 268 in treatment centres.
Since the last Disease Outbreak News, no new cases have been reported from Kenya or Nigeria; and no new country has reported confirmed cases.
Both countries have started a 42-day countdown to declare the end of their outbreaks.
However, the high-level transmission in the Democratic Republic of the Congo calls for continued need for readiness in the region, including cross-border surveillance, points of entry monitoring, timely case detection and coordinated preparedness and response measures.
Six months into the outbreak of Bundibugyo virus disease (BVD) in the Democratic Republic of the Congo, the response has expanded significantly, but further scale up is needed, with rising insecurity remaining the greatest obstacle to the expansion of operations.
The next phase must prioritize quality, reach and community trust, alongside sustained funding, coordination and security to save lives and end the outbreak.
On 18 November 2026, the Director-General of WHO, concurring with the advice of the IHR Emergency Committee formulated at its third meeting, on 17 November 2026, determined that the event continues to constitute a public health emergency of international concern (PHEIC).
Updated recommendations to the government of the Democratic Republic of the Congo and all other States Parties will be issued in the coming days.
Description of the situation
Cases have been reported in five countries since the declaration of the outbreak on 15 May 2026: the Democratic Republic of the Congo, France, Kenya, Nigeria, and Uganda.
The outbreaks in France and Uganda have been controlled since August, while Kenya and Nigeria continue with heightened surveillance as they count down to 42 days, completing two maximum incubation periods since the last confirmed cases were either discharged or medically evacuated from the country.
On 26 October 2026, Switzerland reported the medical evacuation of the case, who received medical care in Geneva, Switzerland.
The patient recovered and was discharged on 11 November testing PCR-negative for Bundibugyo virus for a second time.
On 18 November 2026, the United Kingdom of Great Britain and Northern Ireland reported that a medically evacuated health and care worker from the Democratic Republic of the Congo had recovered and been discharged from hospital.
Democratic Republic of the Congo
An additional 945 confirmed cases, including 480 confirmed deaths, have been reported in the Democratic Republic of the Congo since the previous Disease Outbreak News was published.
In the last 21-day period, as of 17 November, 1417 new confirmed cases were reported, with Ituri accounting for 668 (13% decrease) cases, Nord Kivu for 635 (8% increase) cases, Haut-Uélé for 90 (13% increase) cases, Tshopo for 20 (47% decrease) cases and Nord-Ubangi for four cases. No new cases were reported in Bas-Uélé, Sud Kivu or Sud-Ubangi during that period.
As of 17 November, cumulative confirmed cases have reached 11 613, including 5678 deaths and 3148 recoveries. The overall crude CFR is 48.9%.
Confirmed cases have now been identified in 68 health zones across eight provinces. Forty-eight of the 68 affected health zones reported at least one new case during the preceding 21 days, while 20 reported no recent cases.
Beni, Bunia, and Mandima have reported the highest number of cases and deaths in the preceding 21 days. Ituri remains the most extensively affected province, with 28 of 36 health zones reporting cases during this outbreak, followed by Nord Kivu (17/34), Haut-Uélé (8/13), Tshopo (7/23), Bas-Uélé (4/11), Nord-Ubangi (2/11), Sud Kivu (1/34) and Sud-Ubangi (1/16). Watsa in Haut-Uélé province is the most recently affected health zone, reporting 11 confirmed cases.
Six months into the BVD outbreak, the response has expanded significantly, but transmission remains persistent and geographically widespread. WHO, the national Government and partners have strengthened surveillance, treatment, laboratory capacity and community engagement, yet high community mortality, insecurity, displacement and a fragile health system continue to undermine progress.
The next phase will need to focus on scaling up, but also on improving the reach, quality and impact of the response. Early detection, quality care, contact tracing, infection prevention and community trust remain critical. Sustained funding, strong coordination and safe access to communities will be essential.
The third International Health Regulations (IHR) Emergency Committee meeting regarding the epidemic of BVD in the Democratic Republic of the Congo took place on 17 November. Following the advice of the Committee, the Director-General agreed that the ongoing outbreak remains a PHEIC. Updated recommendations to the government of the DRC and all other States Parties will be issued in the coming days and reported in the next Disease Outbreak News publication.
(...)
While Nord Kivu reported the highest number of cases in the last seven days (235 cases (40% increase compared to the previous seven days) as of 17 November), Ituri remains the most affected province since the outbreak was declared, with 7946 cumulative confirmed cases and 3751 deaths, with CFR of 47%. Nord Kivu follows with 2996 confirmed cases and 1654 deaths, and continues to record the highest provincial CFR, at 55%.
Haut-Uélé has reported 534 cases and 231 deaths, while Tshopo has recorded 109 cases and 35 deaths. The less-affected provinces continue to report substantially fewer cases, but transmission persists in several of them. The continued occurrence of cases across multiple provinces shows that the outbreak remains geographically active even as intensity varies between health zones. Sud-Kivu and Sud Ubangi have not reported cases for more than 42 days.
As of 17 November 2026, the average proportion of contacts seen daily over the previous 14-day period is 81%, remaining below the required threshold of 95% for a daily average of the proportion of contacts seen over the previous 14-day period. Two provinces were at or above the 95% threshold: Bas-Uele (100%, 56/56) and Nord-Ubangi (99%, 140/138) Five provinces were below the threshold: Haut-Uélé (86%; 1741/1495), Ituri (86% (9564/11 104), Nord-Kivu (77%; 16 015/12 313), Tshopo (68%; 720/526), and Sud-Ubangi (63%; 127/80). Strengthened contact follow-up is required, particularly in provinces below the target, to achieve the minimum threshold of 95%.
(...)
Kenya
As of 17 November 2026, the cumulative confirmed cases reported in Kenya are nine, including two deaths, with a crude CFR of 22.2%. All eight secondary cases were epidemiologically linked to the imported index case and associated with one cluster (four family members of the index case and four health and care workers). All seven hospitalized cases have recovered and been discharged (the last case was discharged on 11 November). A 42-day countdown is underway and includes heightened surveillance.
There is currently no evidence of transmission outside this cluster, and there have been no new confirmed cases since 19 October 2026. Additionally, all eight secondary cases were already under quarantine as known contacts when they developed symptoms.
As of 17 November, of the 135 cumulative contacts identified since the first confirmed case, eight subsequently became confirmed cases and nine contacts left Kenya (relevant National IHR Focal Points were notified). All have completed the 21-day follow-up on 11 November 2026.
(...)
Nigeria
On 20 October 2026, Nigeria reported one laboratory-confirmed imported case of BVD in the Federal Capital Territory Abuja. On 26 October 2026, Switzerland reported the medical evacuation of the case, who received medical care in Geneva, Switzerland. The patient recovered and was discharged on 11 November, following two PCR-negative test results for Bundibugyo virus.
As of 13 November, a cumulative of 62 contacts had been identified in Nigeria for follow-up and all the contacts have completed the 21-day follow-up period. National authorities, with support from WHO and partners, have intensified contact tracing, case investigation and infection prevention and control measures, including the provision of essential supplies and personal protective equipment for health workers. Investigations are ongoing to establish the likely source of infection and reconstruct the travel and exposure history of the imported case. WHO has urged countries across the region to strengthen surveillance, laboratory diagnostic capacity, rapid response readiness and cross-border preparedness to mitigate the risk of further transmission.
(...)
Citable reference: World Health Organization (20 November 2026). Disease Outbreak News; Bundibugyo Virus Disease in the Democratic Republic of the Congo, Kenya and Nigeria. Available at: https://www/who.int/emergencies/disease-outbreak.news.item/2026-DON630
Source: World Health Organization, https://www/who.int/emergencies/disease-outbreak.news.item/2026-DON630
____






